ISSN 1301 - 0883 | E-ISSN: 1309-3886
The effect of hydroxychloroquine on ventricular repolarization parameters JTc and JTpc intervals in patients with COVID-19 [Eastern J Med]
Eastern J Med. 2022; 27(1): 112-118 | DOI: 10.5505/ejm.2022.26539

The effect of hydroxychloroquine on ventricular repolarization parameters JTc and JTpc intervals in patients with COVID-19

Önder Bilge1, Murat Çap1, Ferhat Işık1, Rojhat Altindag1, Abdurrahman Akyüz1, Ümit Inci1, Burhan Aslan1, İlyas Kaya1, Mehmet Şahin Adıyaman1, Nesim Aladağ2, Halil Akın3, Bernas Altıntaş1
1Department of Cardiology, University of Health Sciences Gazi Yaşargil Education and Research Hospital, Diyarbakır, Turkey
2Department Of Cardiology,yüzüncü Yıl University Faculty Of Medicine, Van, Turkey
3Department of Cardiology, Sinop State Hospital, Sinop, Turkey

INTRODUCTION: JT and JTp intervals are among the ventricular repolarization parameters and prolongation, just as the QT interval is related to ventricular arrhythmias. This study aims to examine the effect of hydroxychloroquine on JTc and JTpc intervals in individuals hospitalized with COVID-19.
METHODS: We involved 130 COVID-19 patients divided into two groups as the hydroxychloroquine treatment group and the control group, in this study. ECGs of the patients were recorded at admission and after a median of 48 hours following the initiation of hydroxychloroquine treatment. Then, QTc, JTc, and JTpc intervals were measured.
RESULTS: Patients’ average age was 48 (37-66 IQR), and 53% of the individuals were female, while 47% are male. The median basal JTpc interval was 215 ms(195-230 IQR), while JTpc-Day 3 was 220 ms(195-238 IQR). The median basal JTc interval was 320 ms(301-334 IQR), while JTc-Day 3 was 328 ms(306-343 IQR). JTpc and JTc interval in the hydroxychloroquine group have prolonged significantly (p<0.001), while there were no significant changes in the control group for both values (p>0.05).
There was a significant prolongation in the multivariable linear regression analysis in JTc-Day 3 and JTpc-Day 3 after hydroxychloroquine treatment. (ß=-2.589, 95%CI, 2.384-17.894, p=0.011, ß=2.195, 95%CI, 759-14.752, p=0.030, respectively).

DISCUSSION AND CONCLUSION: In this study, we found significant prolongation in JTc and JTpc intervals in the patients who take hydroxychloroquine treatment.

Keywords: COVID-19, hydroxychloroquine, JTc interval, JTpc interval

Corresponding Author: Önder Bilge, Türkiye
Manuscript Language: English
×
APA
NLM
AMA
MLA
Chicago
Copied!
CITE
LookUs & Online Makale